Oppenheimer Reiterates Outperform Rating on The Ensign Group, Inc. (ENSG)

Market Context

The Ensign Group, Inc. operates in the Healthcare sector. The stock currently trades at $183.93 with a market capitalization of $10.0B. The stock has declined 1.3% over the past 52 weeks.

Analyst coverage from Oppenheimer provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for The Ensign Group, Inc.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for The Ensign Group, Inc.

Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 29, 2026	Oppenheimer	Outperform	N/A
Jul 30, 2026	Truist Securities	Hold	N/A
Jul 14, 2026	Truist Securities	Hold	N/A
Feb 09, 2026	RBC Capital	Outperform	N/A
Feb 06, 2026	Truist Securities	Hold	N/A

Related Tools: Analyst Ratings Dashboard | View ENSG Stock Page